# Ernexa Therapeutics Inc.: Form 8-K, filed Feb 11, 2016

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2016-02-11
- Accepted by EDGAR: Feb 11, 2016, 08:31 ET
- Period: 2016-02-11
- Accession: 0001019687-16-005125
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968716005125/ntn_8k-021116.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968716005125/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968716005125/ntn_8k-021116.htm

Filed Feb 11, 2016.
Source: SEC EDGAR, the filing index for accession 0001019687-16-005125. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.